%0 Journal Article
%T Residual ¦ÃH2AX foci as an indication of lethal DNA lesions
%A Judit P Ban¨¢th
%A Dmitry Klokov
%A Susan H MacPhail
%A C Adriana Banuelos
%A Peggy L Olive
%J BMC Cancer
%D 2010
%I BioMed Central
%R 10.1186/1471-2407-10-4
%X To examine this predictive ability further, SiHa human cervical carcinoma cells were exposed to 8 DNA damaging drugs (camptothecin, cisplatin, doxorubicin, etoposide, hydrogen peroxide, MNNG, temozolomide, and tirapazamine) and the fraction of cells that retained ¦ÃH2AX foci 24 hours after a 30 or 60 min treatment was compared with the fraction of cells that lost clonogenicity. To determine if cells with residual repair foci are the cells that die, SiHa cervical cancer cells were stably transfected with a RAD51-GFP construct and live cell analysis was used to follow the fate of irradiated cells with RAD51-GFP foci.For all drugs regardless of their mechanism of interaction with DNA, close to a 1:1 correlation was observed between clonogenic surviving fraction and the fraction of cells that retained ¦ÃH2AX foci 24 hours after treatment. Initial studies established that the fraction of cells that retained RAD51 foci after irradiation was similar to the fraction of cells that retained ¦ÃH2AX foci and subsequently lost clonogenicity. Tracking individual irradiated live cells confirmed that SiHa cells with RAD51-GFP foci 24 hours after irradiation were more likely to die.Retention of DNA damage-induced ¦ÃH2AX foci appears to be indicative of lethal DNA damage so that it may be possible to predict tumor cell killing by a wide variety of DNA damaging agents simply by scoring the fraction of cells that retain ¦ÃH2AX foci.Several DNA repair pathways have evolved to maintain cell viability after exposure of mammalian cells to DNA damaging agents. Sufficiently high doses of drugs or radiation cause cell killing, and it seems reasonable to expect that those cells that can repair DNA damage will survive while those unable to repair their damage will die. Sensitive detection of residual DNA damage at the level of the individual cell could allow us to identify treatment resistant subpopulations within tumors. This possibility can now be examined by making use of the fact that complex DN
%U http://www.biomedcentral.com/1471-2407/10/4